Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUCV | ISIN: US36338D1081 | Ticker-Symbol:
NASDAQ
03.06.24
21:59 Uhr
0,149 US-Dollar
+0,004
+2,76 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GALERA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
GALERA THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur GALERA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.10.Galera Therapeutics, Inc. - 8-K, Current Report7
06.09.NSE - Galera Therapeutics, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities4
04.09.Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition ...60NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of Liberty Resources Acquisition Corp. Liberty Resources...
► Artikel lesen
04.09.Galera Therapeutics, Inc. - 8-K, Current Report3
14.08.Galera Therapeutics plans to dissolve and liquidate assets5
14.08.Galera Therapeutics, Inc. - 10-Q, Quarterly Report1
14.08.Galera Therapeutics: Galera Announces Board Approval of Complete Liquidation and Dissolution132MALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel, proprietary...
► Artikel lesen
08.08.Galera Therapeutics, Inc. - 8-K, Current Report4
03.06.Why Galera Therapeutics (GRTX) Stock Is Nosediving12
03.06.Galera Therapeutics, Inc. - 8-K, Current Report12
13.05.Galera Therapeutics GAAP EPS of -$0.082
13.05.Galera Therapeutics, Inc. - 10-Q, Quarterly Report-
13.05.Galera Therapeutics, Inc. - 8-K, Current Report1
13.05.Galera Therapeutics: Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates213MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics...
► Artikel lesen
03.05.Galera Therapeutics: Galera Adopts Limited Duration Stockholder Rights Agreement256MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the...
► Artikel lesen
28.03.Galera Therapeutics: Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates231MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...
► Artikel lesen
14.11.23Galera Therapeutics: Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates370FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options to optimize shareholder value MALVERN, Pa., Nov. 14...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1